Tuberculosis Evaluation and Care: Resources, Guidelines and Recommendations
Information for Providers and Local Health Departments about evaluation and treatment of TB and LTBI, and Standards of Care for persons with TB in Connecticut. All documents are in PDF unless otherwise noted.
Connecticut Recommendations
- Standards of Care for Connecticut (2/2017)
- Prevention of Tuberculosis in Persons Enrolling in Colleges and Universities in CT (4/2012)
- Electronic Directly Observed Therapy (eDOT) Guidelines and Procedures (11/2016)
- Update on Policy for Distribution of Purified Derivative Protein (PPD) (8/22/2016)
- QuantiFeron Testing Recommendations (3/5/2012)
- Routine Chest X-rays and Tuberculosis (3/2011)
National Guidelines and Recommendations
- CDC TB Guidelines
- CDC Core Curriculum on Tuberculosis: What the Clinician Should Know
- CDC Self Study Modules on Tuberculosis
- Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016)
- Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019
- CDC Resources for TB Screening and Testing of Health Care Personnel
- Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection (6/29/2018)
- Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis (National Tuberculosis Controllers Association and CDC) (2005)
This page last updated 8/03/2021.